Screening in oncology. A warning. Identify Treatment.
Screening (from the English. Screening - mass screening) -
complex of measures in the health care system, carried out in order to detect and prevent the development of
diseases in the population.
The purpose of screening is possible early detection of diseases, which allows for early treatment based on patient relief and reduced mortality (Wikipedia).
In his address to the Federal Assembly, President of the Russian Federation V.V. Putin put forward two main tasks, namely: raising the level of education and health, especially in the field of oncology. This is understandable if we refer to the annual register of oncological diseases of the Russian Federation under the editorship of Academician RAS Kaprin A.D.
The solution of these problems over the years, in more or less a lesser degree, was reflected in the work of the congresses "Radiology". However, the current stage is characterized by the need to create a significant breakthrough in solving problems of oncology. And this, first of all, concerns the early diagnostics of oncological diseases, development of necessary drugs and diagnostic equipment. To solve such an important problem as early diagnosis, it is necessary to develop and implement screening programs. And there are already such programs for cancer of the breast, lung, prostate, melanoma, colorectal cancer. The development, implementation and successful application of screening programs in oncology should be based on an interdisciplinary approach. This, first of all, depends on the close interaction of diagnosticians with clinicians. Equally important is the continuity in the work of doctors diagnosticians. Today we have A sufficient number of high-tech equipment. This is an expert class ultrasound, MSCT with the ability bolus contrasting and 3D multiplanar reconstructions (MPR), 1.5 and 3T MRI, hybrid methods such as SPECT / CT, PET, PET / CT, PET / MRI, angiographic installations, etc. Possibilities and views on diagnostics change many diseases. It is possible not only to assess the anatomical changes, but also functional ones. It will probably take a little more time, and we will be able to go from the diagnosis of macroscopic changes to microscopic. This is facilitated by many techniques that are already being successfully applied now. These are different types of contrast enhancements with the study of perfusion with CT and MRI, this is also DWI, SWI, 3D MR RAGE), 3D TOF MRA and 4D - MRA (for vessels), intellectual technologies: MRI CardioLine, NeuroLine. The main task is to create common views and approaches, in the performed research, analysis of their results, which in combination with the clinical picture of the disease and morphological data allow us to confidently achieve reliable results in the early diagnosis of cancer. Of course, we must not forget that the equipment available in our arsenal allows not only to conduct various studies, but also with success to be used to perform diagnostic manipulations for the purpose of morphological study of detected changes. And as a result - the right choice of type and the amount of treatment needed, evaluation of its effectiveness. All this allows us to achieve not only good results. treatment, increase the survival time after treatment, but also to maintain the patient’s quality of life, as well as reduce financial costs, which also plays an important role. That is, fast, reliable and less expensive.
Along with this, of course, of particular importance, as in previous years, plays the problem of training on the basis of the accumulated material and the emergence of new developments.
I would like to express my gratitude to all members of the organizing committee and personally academician of the Russian Academy of Sciences Ternovomu S.K. for the nomination of my candidacy as president of the congress "Radiology - 2019 ".
I am confident that, as in previous years, we will manage to hold a congress. at a high professional level, interesting and informative.
President of the Congress "Radiology - 2019"